ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $9,000 | +50.0% | 12,714 | +8.5% | 0.00% | +33.3% |
Q3 2020 | $6,000 | -33.3% | 11,714 | 0.0% | 0.00% | -25.0% |
Q2 2020 | $9,000 | -18.2% | 11,714 | 0.0% | 0.00% | -33.3% |
Q1 2020 | $11,000 | -54.2% | 11,714 | 0.0% | 0.01% | -40.0% |
Q4 2019 | $24,000 | -29.4% | 11,714 | 0.0% | 0.01% | -28.6% |
Q3 2019 | $34,000 | -62.2% | 11,714 | 0.0% | 0.01% | -64.1% |
Q2 2019 | $90,000 | -42.3% | 11,714 | 0.0% | 0.04% | -41.8% |
Q1 2019 | $156,000 | -14.8% | 11,714 | 0.0% | 0.07% | -26.4% |
Q4 2018 | $183,000 | -20.4% | 11,714 | 0.0% | 0.09% | -1.1% |
Q3 2018 | $230,000 | -31.5% | 11,714 | 0.0% | 0.09% | -39.1% |
Q2 2018 | $336,000 | +21.3% | 11,714 | 0.0% | 0.15% | +20.8% |
Q1 2018 | $277,000 | – | 11,714 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
Benin Management CORP | 11,714 | $11,000 | 0.01% |